摘要 |
The present invention relates to crystalline forms of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, their production in essentially pure form, and their use. The invention also relates to the pharmaceutical compositions containing the crystalline forms of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine as hydrochloride and to methods of treating hyperproliferative disorders, such as cancer, by administering the compound. |
申请人 |
OSI PHARMACEUTICALS, INC. |
发明人 |
CONNELL, RICHARD, D.;MOYER, JAMES, D.;MORIN, MICHAEL, J.;KAJIJI, SHAMA, M.;FOSTER, BARBARA, A.;FERRANTE, KAREN, J.;NORRIS, TIMOTHY;RAGGON, JEFFREY, W.;SILBERMAN, SANDRA, L. |